Events
to integrated IT solutions. The scope highlights COMPAMED’s unique identity: unlike MEDICA, which focuses on end products and applications, COMPAMED celebrates the often-invisible innovations that make modern healthcare possible.
Industry under pressure, industry on show The context for COMPAMED 2025 could hardly be more complex. The medical technology sector is grappling with stricter regulatory requirements, disrupted supply chains, skills shortages and geopolitical trade restrictions. Yet it is also at the vanguard of digitalisation, AI, robotics and connected care. This duality – pressure and promise – will be visible across COMPAMED and MEDICA. Together, the two fairs expect to welcome more than 5,000 exhibitors and 80,000 visitors from over 160 nations, mirroring last year’s strong international turnout. High-calibre delegations are already confirmed, including a team from the UK’s National Health Service with specialists in paediatrics and neurosurgery.
For suppliers, the message is clear: their innovations are not peripheral but central to navigating medtech’s transformation.
Spotlight on innovation Beyond the exhibition floor, COMPAMED will feature a stage programme designed to bring ‘future tech’ into sharper relief. Topics like microfluidics, organoid development and quantum imaging will be discussed alongside practical sessions on materials and software solutions.
Case studies from the Innovation Forum illustrate the diversity of supplier breakthroughs: ■ Centrifugal microfluidics: Hahn-Schickard’s LabDisk technology standardises isolation of extracellular vesicles, paving the way for more reliable liquid biopsies.
■ Fibre-optic endoscopy: art photonics is developing polycrystalline infrared fibres capable of distinguishing tumour margins in vivo, a leap for surgical precision.
■ Photonic multiplexing: Surfix has built a point-of- care platform detecting multiple biomarkers with lab-level sensitivity in just 15 minutes.
■ Quantum microscopy: Fraunhofer IOF is applying twin photons to sharpen resolution and signal-to- noise in cancer diagnostics.
■ Organoid platforms: CSEM is automating vascularised tumour organoids, offering more predictive drug testing while reducing animal experiments.
Each development underscores the same theme: suppliers are no longer just ‘upstream’ manufacturers but co-creators of clinical progress.
www.medicaldevice-developments.com
Parallel powerhouse Running alongside COMPAMED, MEDICA 2025 will again fill the halls with the latest in medical technology and healthcare delivery. Its new campaign motto – ‘Meet Health. Future. People.’ – encapsulates a focus on digital transformation, AI, robotics and connected care. German Federal Health Minister Nina Warken and North Rhine-Westphalia Health Minister Karl-Josef Laumann will open the fair on 17 November, setting a political backdrop for four days of policy debate and innovation showcases. The German Hospital Conference, also hosted within MEDICA, will address pressing issues such as healthcare workforce shortages, resilience in disaster management and regulatory reform. For suppliers at COMPAMED, MEDICA’s expansive agenda is both complementary and catalytic – reinforcing the importance of upstream innovation in shaping downstream care.
A global marketplace with local support
For international visitors, Messe Düsseldorf is enhancing services this year. A new hotel booking platform, launched with Kuoni Tumlare Congress, offers room contingents near the fair at competitive prices. With halls open from 10am to 6pm for the first three days and until 4pm on the final day, attendees will have an opportunity to explore both COMPAMED and MEDICA. COMPAMED’s significance lies in its ability to provide orientation in turbulent times. It is not simply about showcasing components but about demonstrating how these innovations underpin resilience in global healthcare. Whether through micro-optics that sharpen cancer surgery, software that secures connected devices, or materials that enable sustainability, suppliers are proving indispensable. The medical technology industry is entering an era defined by complexity. COMPAMED 2025 offers clarity, spotlighting the medtech innovations that will shape diagnostics, treatment and patient care in the decade ahead. ●
121
Supplier innovations are central to
navigating medtech’s transformation.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130
